Assessment of DAFILON® Suture Material in Oral Surgery (Mucosal Sutures)
- Conditions
- Oral SurgeryTooth ExtractionDental Implants
- Interventions
- Device: Mucosal Closure
- Registration Number
- NCT04390620
- Lead Sponsor
- Aesculap AG
- Brief Summary
In this non-interventional study (NIS) a polyamide non-absorbable suture (Dafilon) will be evaluated for oral surgery (mucosal closure after e.g. wisdom teeth extraction, implant surgery, etc.) in adult patients
- Detailed Description
In this non-interventional study (NIS) a polyamide non-absorbable suture (Dafilon) will be evaluated for oral surgery (mucosal closure after e.g. wisdom teeth extraction, implant surgery, etc.) in adult patients.
The aim of this NIS is to collect systematically and proactively different clinical parameters regarding safety, effectiveness and performance of Dafilon suture material under the daily routine clinical practice when is intended to be used for oral surgery. All patients enrolled will be prospectively followed until suture removal, which takes place 10 ± 5 days post-operatively (and post-operatively depending on routine clinical practice of each hospital).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 105
- Adult patients undergoing mucosal wound closure using Dafilon as suture material in oral surgery (in the event that more than one incision is performed in the same patient, only one incision will be included).
- Written informed consent regarding the data collection for the PMCF.
- Emergency surgery.
- Oral surgery procedures requiring bone regeneration.
- Pregnancy.
- Patients taking medication that might affect wound healing.
- Patients with hypersensitivity or allergy to the suture material.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description MUCODA Mucosal Closure DAFILON - sterile, monofilament, non-absorbable surgical suture material produced from Polyamide
- Primary Outcome Measures
Name Time Method incidence of combined postoperative complications Grade I and Grade II 10 ± 5 days postoperatively (suture removal) combined incidence of postoperative complications Grade I \& II on a Five Point scale defined by Askar et al. (Grade I: postoperative dentinal hypersensitivity / Oral candidiasis / Angular cheilitis / Exaggerated swelling defined as postoperative enlargement of tissues that exceeds the normal limits associated with a given surgical procedure / Delayed wound healing defined as an unusual deviation from the normal course of healing / Mild postoperative bleeding defined as the presence of small amount of blood in the oral cavity, usually mixed with saliva; Grade II: Flap dehiscence / Membrane exposure / Localized infection of the surgical site / Graft necrosis)
- Secondary Outcome Measures
Name Time Method Wound healing assessment using the visual analogue scale (VAS 1-100) at suture removal 10 ± 5 days postoperative This parameter will be noted by the surgeon using the Visual Analogue Scale (VAS) which state "0" at one end representing "very good wound healing" and "100" at the opposite end representing "very bad wound healing".
Incidence of individual postoperative complications until suture removal 10 ± 5 days postoperative incidence of postoperative complications of Grade I - V on a Five Point scale defined by Askar et al. (Grade I \& II see Primary Outcome; Grade III: Fever / Skin rash / Neuropraxia/paresthesia / Trimus / Osteomyelitis / Septicemia / Sinusitis / Alveolar osteitis / Chymosis / Excessive and severe bleeding / Prolonged exaggerated swelling; Grade IV: Major complications that required immediate hospitalization such as drug induced anaphylaxis or septicemia; Grade V: Major complications that led to irreversible damage such neurotmesis and axonotmesis)
pliability intraoperative Evaluation of pliability with the 5 evaluation levels 'excellent', 'very good', 'good', 'satisfied' and 'poor' into the evaluation scores 5, 4, 3, 2 and 1,
Satisfaction of the patient using the visual analogue scale (VAS 1-100) at suture removal 10 ± 5 days postoperative This parameter will be noted according to the Patient self assessment using the Visual Analogue Scale (VAS) which state "0" at one end representing "completely satisfied" and "100" at the opposite end representing "not at all satisfied".
tensile strength intraoperative Evaluation of tensile strength with the 5 evaluation levels 'excellent', 'very good', 'good', 'satisfied' and 'poor' into the evaluation scores 5, 4, 3, 2 and 1,
knot run down intraoperative Evaluation of knot run down with the 5 evaluation levels 'excellent', 'very good', 'good', 'satisfied' and 'poor' into the evaluation scores 5, 4, 3, 2 and 1,
knot security intraoperative Evaluation of Knot security with the 5 evaluation levels 'excellent', 'very good', 'good', 'satisfied' and 'poor' into the evaluation scores 5, 4, 3, 2 and 1,
Pain assessment using the visual analogue scale (VAS 1-100) at suture removal 10 ± 5 days postoperative This parameter will be noted according to the Patient self assessment using the Visual Analogue Scale (VAS) which state "0" at one end representing "no pain" and "100" at the opposite end representing "maximal pain".
tissue drag intraoperative Evaluation of tissue drag with the 5 evaluation levels 'excellent', 'very good', 'good', 'satisfied' and 'poor' into the evaluation scores 5, 4, 3, 2 and 1,
Trial Locations
- Locations (2)
Universitat Internacional de Catalunya (UIC)
🇪🇸Barcelona, Spain
Praxisklinik für Mund-, Kiefer- und Gesichtschirurgie, Ästhetische und Plastische Chirurgie
🇩🇪Esslingen am Neckar, Germany